Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Capital Expenditures (2020 - 2023)

Privia Health's quarterly Capital Expenditures came in at $23000.0 in Q4 2023, up 53.33% year-on-year from $15000.0 in Q4 2022, and up 27.78% quarter-over-quarter from $18000.0 in Q3 2023.

Privia Health has reported Capital Expenditures for 4 years, with the latest figure at $23000.0 in Q4 2023.

  • For the quarter ending Q4 2023, Capital Expenditures rose 53.33% year-over-year to $23000.0; the trailing twelve-month figure through Dec 2023 stood at $113000.0 (up 8.65% YoY), and the FY2023 full-year result was $113000.0, up 8.65% from the prior year.
  • Capital Expenditures for Q4 2023 stood at $23000.0, up from $18000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $366000.0 in Q2 2020, with the low at $1000.0 in Q3 2020.
  • Average Capital Expenditures over 4 years is $88000.0, with a median of $34000.0 recorded in 2022.
  • Year-over-year, Capital Expenditures surged 19600.0% in 2021 and slumped 91.88% in 2022.
  • Tracing PRVA's Capital Expenditures over 4 years: stood at $1000.0 in 2020, then soared by 15000.0% to $151000.0 in 2021, then sank by 90.07% to $15000.0 in 2022, then jumped by 53.33% to $23000.0 in 2023.
  • The last three Capital Expenditures figures came in at $23000.0 (Q4 2023), $18000.0 (Q3 2023), and $72000.0 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 7.03 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 3.67 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 15.93 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 28,000.00
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 2.25 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 15.33 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 118,000.00
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 12.44 Mn
10 Teladoc Health 1.42 Bn 672.39 Mn 562.57 Mn 34.16 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 23,000.00
Dec 31, 2023 23,000.00
Sep 30, 2023 18,000.00
Sep 30, 2023 18,000.00
Jun 30, 2023 72,000.00
Jun 30, 2023 72,000.00
Dec 31, 2022 15,000.00
Dec 31, 2022 15,000.00
Sep 30, 2022 16,000.00
Sep 30, 2022 16,000.00
Jun 30, 2022 39,000.00
Jun 30, 2022 39,000.00
Mar 31, 2022 34,000.00
Mar 31, 2022 34,000.00
Dec 31, 2021 151,000.00
Dec 31, 2021 151,000.00
Sep 30, 2021 197,000.00
Sep 30, 2021 197,000.00
Jun 30, 2021 199,000.00
Jun 30, 2021 199,000.00
Sep 30, 2020 1,000.00
Sep 30, 2020 1,000.00
Jun 30, 2020 366,000.00
Jun 30, 2020 366,000.00
Mar 31, 2020 13,000.00
Mar 31, 2020 13,000.00